Orilton Herbals Private Limited
Founded in 2020 and headquartered in Delhi, India.
2020 | Delhi (India) | Active
Orilton Herbals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
About Orilton Herbals
Orilton Herbals Private Limited (OHPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 June 2020 (Four years and eight months 21 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Arpan Haldar, Ravi Verma, and Babu serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909DL2020PTC364440
- Company No.
364440
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jun 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Trading
Other Industry
Who are the key members and board of directors at Orilton Herbals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arpan Haldar  | Director | 06-Jun-2020 | Current |
| Ravi Verma | Director | 06-Jun-2020 | Current |
| Babu | Additional Director | 15-Jul-2022 | Current |
Financial Performance of Orilton Herbals.
Orilton Herbals Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Orilton Herbals?
Unlock access to Orilton Herbals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Welcer Herbals Private Limited
Arpan Haldar is a mutual person
- Orilton Buildcon Private Limited
Ravi Verma and Babu are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Orilton Herbals?
Orilton Herbals has a workforce of 0 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Orilton Herbals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orilton Herbals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.